Determine AKT3's role in driving tumor progression, metastasis, and resistance to PI3K/mTOR or chemotherapy in melanoma, glioblastoma, and breast cancer. Identify AKT3 activation as a predictive or prognostic biomarker.
Elucidating AKT3's Role in Tumorigenesis - Discover Isoform-Selective Therapeutic Strategies!
Are you currently facing challenges in elucidating the complex signaling roles of AKT3 in disease pathogenesis or struggling to validate its specific isoform functions in your research? Our AKT3 Analysis Services provide comprehensive, isoform-specific insights through advanced molecular and cellular profiling platforms, accelerating your target validation and therapeutic development pipeline.
Overview of AKT3 Analysis
AKT3, a key serine/threonine kinase in the PI3K pathway, exhibits distinct expression patterns and functions, particularly in brain development and specific cancer subtypes like melanoma and glioblastoma. Recent literature underscores its role in promoting cell survival, metabolism, and resistance to targeted therapies. Comprehensive analysis of AKT3 expression, activation (phosphorylation), and downstream signaling is crucial for understanding its pathological mechanisms and identifying actionable biomarkers.
| Technical Method | Core Principle | Primary Application in AKT3 Analysis |
|---|---|---|
| Isoform-Specific qPCR/ddPCR | Quantitative nucleic acid amplification | Precise measurement of AKT3 mRNA expression levels |
| Western Blot / ELISA | Protein detection via antibody binding | Analysis of total and phospho-AKT3 protein expression |
| IHC | Antigen detection in tissue sections | Spatial localization and semi-quantification of AKT3 in FFPE tissues |
| Kinase Activity Assays | Measurement of substrate phosphorylation | Functional assessment of AKT3 enzymatic activity |
| Next-Generation Sequencing | High-throughput DNA/RNA sequencing | Identification of AKT3 mutations, copy number variations, and fusion genes |
Fig.1 AKT1/2/3 genes and proteins.1
How Creative Biolabs' Service Can Assist Your Project?
We deliver precise, actionable data to demystify AKT3 biology. Our services provide not just raw data points but integrated reports that correlate AKT3 status with cellular phenotypes, helping you validate its role as a driver, a biomarker, or a therapeutic target. We clarify critical questions: Is AKT3 amplified or mutated in your models? What is its activation state under treatment conditions? How does it modulate downstream effectors like GSK-3β and FOXO?
Uncover the Full Scope of Our Analysis – Initiate a Project Consultation!
Service Workflow
01Required Starting Materials
Provide your samples (e.g., cell lysates, RNA/DNA extracts, FFPE tissue blocks) and project objectives (e.g., biomarker correlation, drug response profiling).
02Project Scoping & Assay Design
Our scientists collaborate with you to select the optimal combination of assays (e.g., phospho-protein ELISA + kinase assay) tailored to your biological question.
03Sample Processing & QC
Samples undergo rigorous quality control (e.g., RNA integrity number, protein concentration verification) to ensure data reliability.
04Multi-Platform Profiling Execution
We perform the agreed-upon analyses using calibrated, isoform-selective reagents and standardized protocols across our platforms.
05Data Integration & Bioinformatics Analysis
Results from different assays are synthesized. Advanced bioinformatics tools may be applied for pathway analysis or correlation with clinical parameters.
06Comprehensive Reporting & Consultation
You receive a detailed report with clear data interpretation, contextualized with current literature, and actionable conclusions.
Applications
Cancer Research & Biomarker Discovery
Neurological Disorder Studies
Investigate the involvement of AKT3 in brain development and disorders such as megalencephaly, autism spectrum disorders, and schizophrenia through precise expression and activity profiling in neural tissues or models.
Therapeutic Development Support
Validate AKT3 as a target for isoform-selective inhibitors. Assess the on-target effects and mechanism of action (MoA) of candidate therapeutics by monitoring changes in AKT3 phosphorylation and downstream signaling.
Functional Genomics & Cell Line Characterization
Characterize genetically engineered cell lines (e.g., AKT3 knockout/knockdown) or patient-derived xenograft (PDX) models by confirming the molecular consequences of genetic manipulation at the protein and functional level.
Published Data
Fig.2 Inhibition of Akt activity induces apoptosis in ESCs.2
A study published demonstrated that Akt3, but not Akt1 or Akt2, is essential for ESC maintenance. Using isoform-specific shRNA knockdown and kinase inhibitors, researchers showed that Akt3 depletion triggers significant apoptosis and G1-phase arrest. Mechanistically, this effect is mediated by the kinase-dependent suppression of the p53 pathway. These findings highlight the critical need for isoform-specific AKT3 Analysis Services to distinguish unique signaling roles in stem cell biology and AKT3-driven pathologies like glioma and melanoma.
Why Choose Us?
- Isoform-Specific Expertise: We utilize rigorously validated antibodies and assay conditions specifically optimized to distinguish AKT3 from AKT1/AKT2, eliminating cross-reactivity and ensuring data accuracy for this challenging target family.
- Integrated Multi-Omics Approach: Beyond single assays, we offer correlated analysis across genomic (mutations), transcriptomic (expression), and proteomic (activation) levels, providing a holistic view of AKT3 signaling in your system.
- Pathology-Ready Solutions: Our IHC and tissue-based services are fully compatible with clinical FFPE samples, allowing you to bridge foundational research with translational and clinical biomarker studies seamlessly.
- Data-Driven Strategic Insight: Our reports are crafted by PhD-level scientists who translate complex datasets into clear, biologically relevant conclusions, directly informing your next experimental or development step.
Utilize the Creative Biolabs Advantage – Contact Us for a Customized Quote Today.
Frequently Asked Questions
-
Q: How do you ensure specificity for AKT3 versus AKT1 and AKT2 in your assays?
A: We employ a multi-pronged strategy: using antibodies with published isoform specificity validated by knockout cell lines, designing qPCR primers/probes in unique exon regions, and implementing careful assay optimization.
-
Q: Can you analyze AKT3 activity from formalin-fixed, paraffin-embedded (FFPE) tissue samples?
A: Absolutely. Our IHC and RNA extraction protocols are specifically optimized for FFPE tissues, allowing for the assessment of both AKT3 protein localization/expression and, where suitable, mRNA levels from archived clinical specimens.
-
Q: What downstream signaling readouts can be included in the analysis package?
A: We commonly profile key direct substrates like phospho-PRAS40 and phospho-GSK-3β, as well as pathway nodes such as mTORC1 activity (p-S6K, p-4EBP1). We can customize a panel based on your specific research focus.
-
Q: Do you offer services for profiling AKT3 in response to drug treatments in vitro?
A: Yes. We can design dose-response or time-course studies using your cell models and compounds, measuring changes in AKT3 phosphorylation and activity to elucidate drug MoA or resistance mechanisms.
-
Q: What is the typical sample requirement for a baseline AKT3 expression and activation profile?
A: For cell lysates, 20-50 µg of total protein per sample is typically sufficient for western blot/ELISA. For RNA/DNA analysis, standard nanogram quantities are adequate.
Our popular analysis services targeting AKT3 include but are not limited to the following:
| Cat | Service |
| BAS93-1 | AKT3 Kinase Assay |
| BAS93-2 | AKT3 Mutation Detection Assay |
| BAS93-3 | AKT3 Protein Analysis |
| BAS93-4 | AKT3 Knockdown Assay |
| BAS93-5 | AKT3 Inhibitor Screening |
| BAS93-6 | AKT (pS473) ELISA Assay |
Contact Us
Creative Biolabs provides definitive, isoform-focused AKT3 Analysis Services designed to empower your research in oncology, neuroscience, and therapeutic development. By combining technical precision with deep biological insight, we deliver the clarity needed to advance your projects from mechanistic understanding to translational application. Advance your research through expert collaboration, initiate a technical inquiry today.
References
- Hua, Hui, et al. "Targeting Akt in cancer for precision therapy." Journal of Hematology & Oncology 14.1 (2021): 128. Distributed under CC BY-SA 4.0, without modification. Doi: https://doi.org/10.1186/s13045-021-01137-8.
- Wang, Ling, et al. "Akt3 is responsible for the survival and proliferation of embryonic stem cells." Biology Open 6.6 (2017): 850-861. Distributed under CC BY 3.0, without modification. Doi：https://doi.org/10.1242/bio.024505.
For Research Use Only.